Partial meniscus replacement using Spongioflex®
Official title: Sterile Allogeneic Spongioflex® Allograft As Partial Meniscal Replacement After Incomplete Meniscal Loss, an Investigator-initiated Trial
Run by Maria-Josef-Hospital Greven · NCT06775197 · Data updated 2026-11-12
This study is testing a new type of graft called Spongioflex® to see if it can help younger, active people with meniscus injuries recover better than with traditional methods and avoid future knee problems.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 60 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Maria-Josef-Hospital Greven Academic / other |
| Locations | 1 site (Greven, North Rhine-Westphalia) |
| Status | Recruiting |
| Started | November 5, 2024 |
| Main results expected | November 5, 2029 |
| Study ends | November 5, 2031 |
| Registry record updated | January 15, 2025 |
| Trial ID | NCT06775197 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are males and females aged 18-60 with partial loss of the lateral or medial meniscus and associated joint line pain.
✕Probably not a fit
Patients over 60 years old, those with significant knee instability, or advanced cartilage damage will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates the effectiveness of a novel graft, Spongioflex®, for partial meniscal replacement in patients with meniscal injuries. The study aims to determine if this biological material can provide better outcomes compared to traditional replacement methods and prevent the progression to knee arthrosis or the need for knee prosthesis. Patients will undergo the procedure and their postoperative function will be assessed through MRI and clinical knee scores. The trial focuses on younger, active individuals with specific types of meniscal damage.
Why it matters
Potential benefit: If successful, this approach could significantly improve knee function and delay the onset of arthritis in patients with meniscal injuries.
How similar studies have gone: While this approach is novel, previous studies have shown promising results with similar biological grafts in improving knee function.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria:
1. Patients (male and female) with:
2. Partial loss of portions of the
* lateral meniscus and lateral joint line pain OR
* medial meniscus and medial joint line pain
3. sufficient standing of the peripheral rim, so that the procedure can be performed
4. Age: 18-60 years
5. signed written informed consent to the study and to provide the scientific data in pseudonymized form
Exclusion Criteria:
1. The presence of anterior cruciate ligament insufficiency which is not resolved by reconstruction of the anterior cruciate ligament within 16 weeks after partial meniscal implantation.
2. Axial deviation (\>2° varus or valgus)
3. realignment osteotomy not performed within 12 weeks
4. advanced cartilage damage (grade III according to ICRS) and osteoarthrosis in the affected compartment (grade III according to Kellgren and Lawrence \[33\])
5. Extension deficit of more than 3° compared to the opposite side or a knee flexion of less than 125°
6. inflammatory arthritis or synovitis on the treated knee
7. BMI greater than 30 kg/m²
8. \<18 years, \>60 years
9. Chronic pain patients
10. only for patients who will be operated:
1. with increased anaesthesiologic risk, e.g., with known or predicted difficult airway
2. with increased risk of bleeding
3. with increased risk of infection
4. with necrotic, infected, or poorly perfused host sides
5. history of allergic reactions
6. acute hypersensitivity reactions to the IMP or any of its excipients
7. pregnant woman
Where it's running
-
Maria-Josef-Hospital Greven GmbH
Greven, North Rhine-Westphalia, Germany Recruiting
Study contacts
- Principal investigator: Clemens Kösters, PD, Dr. med — Maria-Josef-Hospital Greven GmbH
- Study coordinator: Clemens Kösters, PD, Dr. med.
- Email: Clemens.Koesters@mjh-greven.de
- Phone: +49-2571-502-12001
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Intraoperative Energy Use During ACL Surgery
This study tests how much workload a surgeon experiences during ACL reconstruction procedures while wearing a Hexoskin shirt.
-
Adding bone marrow aspirate to knee arthroscopy for meniscus and cartilage injuries
This trial will test whether giving a small bone marrow aspirate injection during knee arthroscopy helps adults (18–64) with meniscal tears or focal cartilage damage have less pain and better knee function.
-
Repairing longitudinal meniscus tears using fibrin clots
This study is testing if using a special treatment called fibrin clots during surgery can help people with meniscus tears heal better than the usual repair methods.
-
Ultrasound-guided betamethasone injection into the meniscal wall
This trial will test whether an ultrasound-guided betamethasone injection into the meniscal wall provides faster pain relief than a saline injection for adults with degenerative meniscal pain.
-
Assessment of meniscal root tears treated with suture to the posterior cruciate ligament
This study tests a new surgical method for fixing meniscal root tears in the knee to see if it helps patients recover better and avoid future problems like arthritis.
-
Partial meniscus replacement using Spongioflex® allograft for knee function improvement
This study is testing if using a special graft to replace part of the meniscus can help adults with knee pain feel better and avoid more surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.